Related references
Note: Only part of the references are listed.Inside the heart of COVID-19
Rui Adao et al.
CARDIOVASCULAR RESEARCH (2020)
Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19
Reinhold Kreutz et al.
CARDIOVASCULAR RESEARCH (2020)
Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications
Eleanor Murray et al.
CARDIOVASCULAR RESEARCH (2020)
CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic
Marijke Linschoten et al.
EUROPEAN HEART JOURNAL (2020)
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo et al.
JAMA CARDIOLOGY (2020)
Endocrine and metabolic link to coronavirus infection
Stefan R. Bornstein et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
撤稿声明: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 (Retraction of Vol 382, art no E102, 2020)
Mandeep R. Mehra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic
Marijke Linschoten et al.
EUROPEAN HEART JOURNAL (2020)
Novel findings in neutrophil biology and their impact on cardiovascular disease
Aldo Bonaventura et al.
CARDIOVASCULAR RESEARCH (2019)
What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER?
Maciej Banach et al.
CARDIOVASCULAR RESEARCH (2019)
Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology
Jose Tunon et al.
CARDIOVASCULAR RESEARCH (2019)
Anti-PCSK9 treatment: is ultra-low low-density lipoprotein cholesterol always good?
Davide Noto et al.
CARDIOVASCULAR RESEARCH (2018)
Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications
Kulbhushan Tikoo et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Endothelial protection, AT1 blockade and cholesterol-dependent oxidative stress -: The EPAS trial
Henning Morawietz et al.
CIRCULATION (2006)
Share Paper
